艾塞那肽聚乳酸-羟基乙酸共聚物纳米粒制备及体外评价
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Preparation and in vitro evaluation of exenatide-loaded poly (lactic-co-glycolic acid) nanoparticles
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨呼出气一氧化氮(fractional exhaled nitric oxide,FeNO)检测用于诊断咳嗽变异性哮喘(cough variant asthma,CVA)的临床价值及其影响因素。方法:连续收集2015年10月到2016年9月于我院就诊的慢性咳嗽患者607例,首先完成FeNO检测,之后通过支气管激发试验或支气管舒张试验并结合病史作为诊断CVA的标准,绘制FeNO诊断CVA的受试者工作特征曲线(receiver operating characteristic curve,ROC曲线),确定其最佳阈值;建立logisitic回归模型,通过模型分析筛选与CVA相关的因素,根据ROC曲线评价FeNO及FeNO联合其他相关因素对CVA的诊断价值。结果:607例患者中最终诊断CVA患者331例,非CVA患者276例。CVA组的FeNO水平明显高于非CVA组[(54.7±44.5) ppb vs. (19.8±11.9) ppb,P=0.000];FeNO用于判定CVA的最佳阈值为31 ppb,约登指数最大值为0.507 6,ROC曲线下面积(area under curve,AUC)为0.794,此时检验的敏感度为61.63%,特异度为89.13%,阳性预测值为87.18%,阴性预测值为65.95%;年龄增高会引起FeNO下降,FeNO联合年龄、吸烟史诊断CVA的AUC为0.813,单用FeNO时的AUC为0.794,但两者差异无统计学意义(P=0.224)。结论:FeNO检测是诊断CVA的有效辅助手段,有助于慢性咳嗽的鉴别诊断;FeNO联合患者年龄、吸烟史诊断CVA价值不优于单用FeNO的诊断价值。

    Abstract:

    Objective:To prepare exenatide-loaded poly(lactic-co-glycolic acid)(PLGA) nanoparticles,and to evaluate its in vitro ef-fect and characteristics. Methods:The orthogonal experimental design was used to screen out the optimal formulation and process of exenatide-loaded PLGA nanoparticles,and dynamic light scattering and a transmission electron microscope were used for characteri-zation. In vitro simulation of gastrointestinal fluid and Caco-2 cell model were used to evaluate its stability,cellular uptake,and cellular transport. Results:The optimal formulation and process were obtained by the orthogonal design,i.e.,a volume ratio of internal water phase to oil phase of 1∶5,an ultrasonic power of 200 W,an ultrasonic time of 4 minutes,a concentration of polyvinyl alcohol of 2%,and a volume ratio of primary emulsion to external water phase of 1∶20. The nanoparticles obtained had a diameter of 116.2 nm and the transmission electron microscope showed that PLGA nanoparticles had a sphere-like shape with a regular surface. The in vit-ro study demonstrated that PLGA nanoparticles significantly prolonged the release of exenatide in gastrointestinal fluid and improved its stability(P<0.05),and 50% of exenatide was retained after 4-hour culture in simulated gastric fluid,while 80% was retained after 4-hour culture in simulated intestinal juice. The cell experiment showed that the uptake and transport of PLGA nanoparticles in the experimental group were 7 and 5 times those in the control group(P<0.05). Conclusion:PLGA nanoparticles may be a potential effi-cient oral drug delivery system for exenatide.

    参考文献
    相似文献
    引证文献
引用本文

朱德弟,董平,张健,许颖,吴海英.艾塞那肽聚乳酸-羟基乙酸共聚物纳米粒制备及体外评价[J].重庆医科大学学报,2018,(11):1475-1481

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-12-23
  • 出版日期:
文章二维码